Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 2% minoxidil with or without microneedling for female androgenetic alopecia
ChiCTR2300077296Phase 3Not yet recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of minoxidil in androgenetic alopecia (AGA) (3 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: Target area non-vellus hair count at Week 24. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2300077296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077296.